50% ethanol
The ethanol-induced chronic alcoholism model in rats is a SCI gold-standard pathological model based on long-term gradient ethanol exposure to simulate persistent excessive drinking in humans, which accurately recapitulates the progressive pathological process of chronic alcoholism-induced hepatic metabolic damage, systemic oxidative stress, inflammatory disorder, neurotoxicity and multi-organ injury. Long-term continuous ethanol intake is metabolized by alcohol dehydrogenase to produce a large amount of acetaldehyde, causing hepatic lipid metabolism disorder, abnormal lipid accumulation, hepatic steatosis, inflammatory infiltration and early liver fibrosis. Excessive ethanol metabolism breaks the redox homeostasis of the body, induces massive ROS accumulation and antioxidant system depletion, triggers systemic chronic low-grade inflammation, and promotes the cascading release of pro-inflammatory factors such as TNF-α, IL-6 and IL-1β. In addition, ethanol penetrates the blood-brain barrier, disrupts central neurotransmitter balance, impairs synaptic plasticity of hippocampal and cortical neurons, and induces neurotoxic phenotypes including alcohol dependence, cognitive decline and behavioral abnormalities. SD rats possess stable metabolism, moderate ethanol tolerance and uniform organ injury phenotypes with minimal individual differences and excellent reproducibility. This model perfectly recapitulates progressive clinical features of chronic alcoholic fatty liver, alcoholic hepatitis, nerve damage and immune disorder, and is widely used for elucidating alcoholism pathogenesis and preclinical pharmacodynamic evaluation of hepatoprotective, detoxifying, neuroprotective and anti-alcohol dependence candidates.
SPF-grade SD rats aged 6–8 weeks with a body weight of 180–220 g were used, and male rats were preferred. Male SD rats have stable hepatic ethanol metabolizing enzyme activity, minimal hormone interference and regular responses to chronic ethanol stimulation. The progressive phenotypes of liver injury, oxidative stress and neurotoxicity are uniform and stable without spontaneous tolerance or extreme individual differences, serving as the international standard strain for chronic alcoholism research. All rats were housed in an SPF barrier system with constant temperature and humidity, 12 h light/dark cycle, and ad libitum access to food and water. Formal modeling was initiated after 7 days of adaptive sterile feeding to stabilize metabolic and stress status. Environmental interference factors such as noise, drastic temperature and humidity changes and breeding stress were strictly controlled throughout the experiment to ensure consistent metabolic levels and synchronous pathological damage progression among all groups.
After modeling, rats in the model group presented typical chronic alcoholism signs: listlessness, decreased activity, slow response, dry and messy fur, reduced diet and water intake, significantly slowed body weight growth rate, and partial individuals showed mild drowsiness and motor fatigue. The overall status was significantly different from that of the blank group, confirming the preliminary formation of the chronic alcoholism model.
Serum biochemical detection showed that the activities of core liver function indexes (ALT, AST, ALP) in the model group were significantly increased, with massive accumulation of total cholesterol (TC) and triglyceride (TG) and obvious lipid metabolism disorder, indicating ethanol-mediated hepatocyte damage and abnormal lipid metabolism, which conforms to the core biochemical characteristics of chronic alcoholic liver injury and serves as the key quantitative criterion for successful modeling.
HE staining of liver tissues showed typical pathological phenotypes of chronic alcoholic liver injury: diffuse fatty vacuolar degeneration of hepatocytes, loose and transparent cytoplasm, disordered hepatic cord arrangement, mild destruction of hepatic lobule structure and a small amount of inflammatory cell infiltration in the portal area, without severe liver fibrosis or cirrhosis, which accurately corresponds to the pathological characteristics of early to mid-stage clinical chronic alcoholic liver disease with stable and typical modeling phenotypes.
The contents of ROS and MDA in serum and liver tissues of the model group were significantly increased, while the activities of antioxidant enzymes SOD and GSH-Px were significantly decreased with obvious oxidative stress imbalance. Meanwhile, the expression of core inflammatory factors (TNF-α, IL-6, IL-1β) was greatly upregulated, forming a persistent chronic inflammatory state, which conforms to the oxidative stress-inflammation cascade injury mechanism of chronic ethanol poisoning and serves as the core academic gold standard for successful model construction.
As a SCI-certified gradient-induced chronic alcoholism gold-standard model, it adopts a progressive ethanol intervention protocol to perfectly simulate the real clinical course of long-term drinking and cumulative poisoning in humans, avoiding acute damage deviation caused by one-time high-concentration alcohol exposure. It has a standardized modeling cycle and stable pathological phenotypes, and can simultaneously recapitulate multi-dimensional pathological characteristics including lipid metabolism disorder, oxidative stress injury, chronic low-grade inflammation and neurobehavioral abnormalities. SD rats have high tolerance, extremely low modeling mortality and excellent intra-group data uniformity, with far better experimental reproducibility than acute alcohol models. It features simple operation, controllable dosage and low cost, and is suitable for multi-directional drug screening such as hepatoprotection, anti-oxidation, anti-inflammation, neuroprotection and anti-alcohol dependence. With strong project innovation and highly recognized data, it is fully applicable for project declaration, master and doctoral theses and high-score SCI publication.
The ethanol-induced chronic alcoholism model in rats is corely applied to the research of chronic alcoholic liver injury mechanism, oxidative stress-inflammation interactive disorder and alcoholic neurotoxic damage mechanism. It is specially used for screening and evaluating traditional Chinese medicine compounds, natural active ingredients, small chemical molecules and functional preparations with effects of hepatoprotection and lipid-lowering, anti-oxidation, anti-inflammation, neuroprotection and alcohol metabolism disorder improvement. It is widely used in the elucidation of alcoholic liver disease pathogenesis, target exploration of multi-organ injury induced by alcoholism, and preclinical pharmacodynamic evaluation of new anti-alcoholism drugs, serving as an essential core standardized model for metabolic pharmacology, liver disease pharmacology and neurotoxicology research.
ethanol-induced chronic alcoholism rat model,chronic alcoholic liver disease model,long-term ethanol exposure,alcohol dependence animal model,hepatic and neurotoxicity induced by alcohol

We're here to help! Whether you have questions about our products, need support, or want to share feedback, we'd love to hear from you. Please reach out through any of the methods below, and our team will get back to you as soon as possible.